AVXL
Price
$4.86
Change
+$0.04 (+0.83%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
430.66M
21 days until earnings call
Intraday BUY SELL Signals
RNXT
Price
$1.02
Change
-$0.04 (-3.77%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
38.85M
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVXL vs RNXT

Header iconAVXL vs RNXT Comparison
Open Charts AVXL vs RNXTBanner chart's image
Anavex Life Sciences
Price$4.86
Change+$0.04 (+0.83%)
Volume$22.89K
Capitalization430.66M
RenovoRx
Price$1.02
Change-$0.04 (-3.77%)
Volume$470
Capitalization38.85M
AVXL vs RNXT Comparison Chart in %
AVXL
Daily Signal:
Gain/Loss:
RNXT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVXL vs. RNXT commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and RNXT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AVXL: $4.82 vs. RNXT: $1.06)
Brand notoriety: AVXL and RNXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 66% vs. RNXT: 60%
Market capitalization -- AVXL: $430.66M vs. RNXT: $38.85M
AVXL [@Biotechnology] is valued at $430.66M. RNXT’s [@Biotechnology] market capitalization is $38.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 1 FA rating(s) are green whileRNXT’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 1 green, 4 red.
  • RNXT’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVXL and RNXT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 3 TA indicator(s) are bullish while RNXT’s TA Score has 6 bullish TA indicator(s).

  • AVXL’s TA Score: 3 bullish, 5 bearish.
  • RNXT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RNXT is a better buy in the short-term than AVXL.

Price Growth

AVXL (@Biotechnology) experienced а +17.56% price change this week, while RNXT (@Biotechnology) price change was +4.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

AVXL is expected to report earnings on Feb 05, 2026.

RNXT is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($431M) has a higher market cap than RNXT($38.8M). AVXL YTD gains are higher at: 35.393 vs. RNXT (26.175). RNXT has higher annual earnings (EBITDA): -11.62M vs. AVXL (-46.38M). AVXL has more cash in the bank: 103M vs. RNXT (10M). AVXL has less debt than RNXT: AVXL (88.2K) vs RNXT (236K). RNXT has higher revenues than AVXL: RNXT (928K) vs AVXL (0).
AVXLRNXTAVXL / RNXT
Capitalization431M38.8M1,111%
EBITDA-46.38M-11.62M399%
Gain YTD35.39326.175135%
P/E RatioN/AN/A-
Revenue0928K-
Total Cash103M10M1,030%
Total Debt88.2K236K37%
FUNDAMENTALS RATINGS
AVXL: Fundamental Ratings
AVXL
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVXLRNXT
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 28 days ago
85%
Declines
ODDS (%)
Bearish Trend 21 days ago
83%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signal:
Gain/Loss:
RNXT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FNLC26.710.47
+1.79%
First Bancorp
ADT8.250.11
+1.35%
ADT
DIS113.530.55
+0.49%
Walt Disney Company (The)
AHCO10.54-0.07
-0.66%
AdaptHealth Corp
PMEC0.99-0.03
-3.05%
Primech Holdings Ltd

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+3.88%
PLRX - AVXL
48%
Loosely correlated
+1.55%
TENX - AVXL
47%
Loosely correlated
+21.40%
AXON - AVXL
45%
Loosely correlated
-1.92%
VCYT - AVXL
41%
Loosely correlated
-1.39%
ARRY - AVXL
41%
Loosely correlated
-6.70%
More

RNXT and

Correlation & Price change

A.I.dvisor tells us that RNXT and AVXL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and AVXL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
+1.44%
AVXL - RNXT
30%
Poorly correlated
+3.88%
GNPX - RNXT
30%
Poorly correlated
+19.58%
SPRB - RNXT
29%
Poorly correlated
-3.84%
CYTK - RNXT
28%
Poorly correlated
+2.01%
ANTX - RNXT
27%
Poorly correlated
+3.97%
More